Precision Medicine for cancer
Powered by AI

Imagene provides a disruptive AI-based genomic testing solution
to leverage the patient's histological data for personalized therapy.
shape

Our mission

icon
Assist cancer patients to receive the optimal treatment
that medicine can offer by making genomic testing accessible and leverage
their histological data for personalized therapeutic strategies.

Our solution

Cancer diagnostic focus on pathological and molecular testing. Both are conducted by advanced technology which depends on limited amount of tissue, and therefore does not allow wide and extensive diagnosis. Further, genomic analysis, infrastructure and personnel are highly expensive and the overall diagnosis require prolong time to report. These four factors can be improve significantly with in silico and AI based algorithms.

We believe that no structure and assumptions should become a barrier to personal treatment. Imagene brings the potential of accurate, fast, low cost, actionable, standardized, and routine screening to all cancer patients

avatar

Prof. Peled

Director of the Oncology Institute, Shaare Zedek Medical Center

Our Team

icon

Dean Bitan

Co-founder & CEO
jonathan

Jonathan Zalach

Co-founder & Chief Data Scientist
shahar

Shahar Porat

Co-founder & CTO
nurit

Nurit Paz-Yaacov, Ph.D

Chief Scientific Officer
member2

Prof. Nir Peled, MD Ph.D

Medical Director
member4

Inbal Gazy, Ph.D

Researcher
member4

Assaf Avinoam

Data Scientist
member3

Ido Hayun, MD

Researcher
member4

Mirel Bitan

Research assistant
member2

Yoav Falah

Analyst

Reveal the molecular patterns

icon
shape1
shape2

Partner with us

icon
Imagene works with pharmaceutical companies, medical centers, academic institutions,
genomic providers and individuals, to make personalized treatment accessible